Method of crosslinking glycosaminoglycans
US-11807726-B2 · Nov 7, 2023 · US
Galderma Res & Dev holds 229 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 229 |
| Recent patents | 3 |
| First publication | Jan 20, 2015 |
| Latest publication | Nov 7, 2023 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-11807726-B2 · Nov 7, 2023 · US
US-11731973-B2 · Aug 22, 2023 · US
US-11730814-B2 · Aug 22, 2023 · US
US-11518767-B2 · Dec 6, 2022 · US
US-2022081519-A1 · Mar 17, 2022 · US
Representative or frequently cited publications from precomputed assignee stats.
US-11807726-B2 · Nov 7, 2023 · US
US-11731973-B2 · Aug 22, 2023 · US
US-11730814-B2 · Aug 22, 2023 · US
US-11518767-B2 · Dec 6, 2022 · US
US-2022081519-A1 · Mar 17, 2022 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P17/00 | 138 |
| A61P17/10 | 114 |
| A61K9/0014 | 82 |
| A61P17/06 | 72 |
| A61P35/00 | 59 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 197 |
| Chemistry & Metallurgy | 111 |
| Physics | 25 |
| Cross-Sectional Technologies | 15 |
| Operations & Transport | 9 |
| Mechanical Engineering | 2 |
| Electricity | 2 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.